Literature DB >> 30704671

Mycoplasma Pneumoniae Pericarditis.

Aishwarya Vijay1, John C Stendahl2, Lynda E Rosenfeld3.   

Abstract

Mycoplasma pneumoniae is an atypical bacterium that is frequently implicated in respiratory infections, but uncommonly identified as a cause of pericarditis. We report 2 cases of pericarditis attributed to M. pneumoniae that were characterized by prolonged respiratory prodromes, pericardial, and pleural effusions, elevated inflammatory markers, and relapsing clinical courses. In conclusion, our experience suggests that M. pneumoniae should be considered as a potential cause in cases of pericarditis associated with upper respiratory symptoms, pneumonia, pleural effusions, arthralgia, and/or a recurrent/refractory clinical course. The availability of effective antibiotic treatment makes this an important diagnosis to make.
Copyright © 2019 Elsevier Inc. All rights reserved.

Entities:  

Year:  2019        PMID: 30704671     DOI: 10.1016/j.amjcard.2019.01.014

Source DB:  PubMed          Journal:  Am J Cardiol        ISSN: 0002-9149            Impact factor:   2.778


  4 in total

Review 1.  [Clinical implications of the genus Mycoplasma].

Authors:  D Gómez Rufo; E García Sánchez; J E García Sánchez; M García Moro
Journal:  Rev Esp Quimioter       Date:  2021-03-18       Impact factor: 1.553

2.  Chlamydia pneumoniae-associated pleuropericarditis: a case report and systematic review of the literature.

Authors:  Konstantinos G Kyriakoulis; Anastasios Kollias; George E Diakos; Ioannis P Trontzas; Eleni Fyta; Nikolaos K Syrigos; Garyphallia Poulakou
Journal:  BMC Pulm Med       Date:  2021-11-22       Impact factor: 3.317

Review 3.  Pseudomembranous necrotizing laryngotracheobronchitis due to Mycoplasma pneumoniae: a case report and literature review.

Authors:  Wu Lei; Zhang Fei-Zhou; Chen Jing; Li Shu-Xian; Wu Xi-Ling; Tang Lan-Fang
Journal:  BMC Infect Dis       Date:  2022-02-23       Impact factor: 3.090

Review 4.  Thrombosis associated with mycoplasma pneumoniae infection (Review).

Authors:  Jingwei Liu; Yumei Li
Journal:  Exp Ther Med       Date:  2021-07-07       Impact factor: 2.447

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.